1. Home
  2. YYGH vs ADVM Comparison

YYGH vs ADVM Comparison

Compare YYGH & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YYGH
  • ADVM
  • Stock Information
  • Founded
  • YYGH 2010
  • ADVM 2006
  • Country
  • YYGH Singapore
  • ADVM United States
  • Employees
  • YYGH N/A
  • ADVM N/A
  • Industry
  • YYGH
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • YYGH
  • ADVM Health Care
  • Exchange
  • YYGH NYSE
  • ADVM Nasdaq
  • Market Cap
  • YYGH 40.2M
  • ADVM 47.4M
  • IPO Year
  • YYGH 2024
  • ADVM 2014
  • Fundamental
  • Price
  • YYGH $2.71
  • ADVM $2.63
  • Analyst Decision
  • YYGH
  • ADVM Strong Buy
  • Analyst Count
  • YYGH 0
  • ADVM 5
  • Target Price
  • YYGH N/A
  • ADVM $23.80
  • AVG Volume (30 Days)
  • YYGH 333.9K
  • ADVM 304.6K
  • Earning Date
  • YYGH 08-21-2025
  • ADVM 08-11-2025
  • Dividend Yield
  • YYGH N/A
  • ADVM N/A
  • EPS Growth
  • YYGH N/A
  • ADVM N/A
  • EPS
  • YYGH N/A
  • ADVM N/A
  • Revenue
  • YYGH $41,103,389.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • YYGH N/A
  • ADVM N/A
  • Revenue Next Year
  • YYGH N/A
  • ADVM $18.82
  • P/E Ratio
  • YYGH N/A
  • ADVM N/A
  • Revenue Growth
  • YYGH 29.37
  • ADVM N/A
  • 52 Week Low
  • YYGH $0.72
  • ADVM $1.78
  • 52 Week High
  • YYGH $3.16
  • ADVM $10.14
  • Technical
  • Relative Strength Index (RSI)
  • YYGH N/A
  • ADVM 54.24
  • Support Level
  • YYGH N/A
  • ADVM $2.50
  • Resistance Level
  • YYGH N/A
  • ADVM $2.75
  • Average True Range (ATR)
  • YYGH 0.00
  • ADVM 0.21
  • MACD
  • YYGH 0.00
  • ADVM 0.05
  • Stochastic Oscillator
  • YYGH 0.00
  • ADVM 76.47

About YYGH YY GROUP HOLDING LIMITED

YY Group Holding Ltd is a data and technology-driven company focused on developing enterprise intelligent labor matching services and smart cleaning services, founded in Singapore. Through its subsidiaries, it provides enterprise manpower outsourcing and smart cleaning services in Singapore, Malaysia, and other countries. The group's reportable segments are Manpower outsourcing services and Cleaning Service. Maximum revenue is generated from the Cleaning Service segment, which is engaged in acting as a contractor to provide long-term cleaning services to hotels and shopping malls, including the areas of toilets, common areas, bin centers, elevators, etc. Geographically, a majority of the group's revenue is generated from its operations in Singapore and Malaysia.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: